NextCure NXTC
NASDAQ NXTC
$4.72 -0.69 (-12.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

NextCure (NXTC) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

NextCure's Return on Capital Employed [ROCE] came in at -183.80% for Q2 2026, down 46.84 percentage points from -136.95% a year earlier and down 32.95 percentage points from the prior quarter.

Analysis

NextCure (NXTC) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, NextCure's Return on Capital Employed [ROCE] was -104.84%, down 41.87 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last five years, with a five-year change of -92.00 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -62.98% in FY2024 (-17.65 pp), -45.33% in FY2023 (-8.14 pp), -37.18% in FY2022 (-10.77 pp) and -26.41% in FY2021 (-13.57 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -184.70% (Q3 2025) to -26.98% (Q3 2021).
  • Year-over-year, Return on Capital Employed [ROCE] has declined for 22 consecutive quarters, with an average year-over-year change of -56.91 percentage points over the last eight quarters.
  • The year-over-year drop in Return on Capital Employed [ROCE] has ranged between 9.69 percentage points (Q1 2023) and 112.84 percentage points (Q3 2025) over the last five years.
  • Business Quant data shows NXTC's Return on Capital Employed [ROCE] at -150.85% (Q1 2026), -167.82% (Q4 2025) and -184.70% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 NextCure 25.06 Mn -95.70 Mn - -183.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -183.80%
Mar 31, 2026 -150.85%
Dec 31, 2025 -167.82%
Sep 30, 2025 -184.70%
Jun 30, 2025 -136.95%
Mar 31, 2025 -77.74%
Dec 31, 2024 -78.59%
Sep 30, 2024 -71.85%
Jun 30, 2024 -67.53%
Mar 31, 2024 -61.48%
Dec 31, 2023 -53.21%
Sep 30, 2023 -49.69%
Jun 30, 2023 -47.94%
Mar 31, 2023 -42.55%
Dec 31, 2022 -42.67%
Sep 30, 2022 -39.12%
Jun 30, 2022 -35.66%
Mar 31, 2022 -32.86%
Dec 31, 2021 -29.06%
Sep 30, 2021 -26.98%
API Access

NextCure Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NXTC&period=max&api_key=YOUR_API_KEY